Blood Coagulation Disorders
1
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Universal BiosensorsAustralia - Rowville
1 programStudy to Test the Accuracy of a Prototype Handheld PT/INR DeviceN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
CSL BehringBeriplex® P/N
Universal BiosensorsStudy to Test the Accuracy of a Prototype Handheld PT/INR Device
Clinical Trials (2)
Total enrollment: 216 patients across 2 trials
Efficacy and Safety Study of BERIPLEX® P/N (Kcentra) Compared With Plasma in Patients With Acute Major Bleeding Caused by Anticoagulant Therapy
Start: Jun 2008Est. completion: Nov 2010216 patients
Phase 3Completed
Study to Test the Accuracy of a Prototype Handheld PT/INR Device
Start: May 2011Est. completion: Nov 2011
N/AUnknown
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 late-stage (Phase 3) programs — potential near-term approvals
2 companies competing in this space